Doubtful clinical benefit of casirivimab-imdevimab treatment for disease severity outcome of high-risk patients with SARS-CoV-2 delta variant infection.
Eur J Intern Med
; 100: 137-139, 2022 06.
Article
in English
| MEDLINE | ID: covidwho-1859503
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
SARS-CoV-2
/
COVID-19 Drug Treatment
Type of study:
Prognostic study
Topics:
Variants
Limits:
Humans
Language:
English
Journal:
Eur J Intern Med
Journal subject:
Internal Medicine
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS